These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6453176

  • 21. [Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)].
    Nagasaka T.
    Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):757-66. PubMed ID: 6454322
    [Abstract] [Full Text] [Related]

  • 22. Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
    Szarvas Z, Zsolnai B.
    Acta Chir Hung; 1984 Jun; 25(4):269-76. PubMed ID: 6240879
    [Abstract] [Full Text] [Related]

  • 23. [A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body].
    Takeda M, Kubo K, Fukushima M, Hirayama J, Sekiguchi M.
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2113-7. PubMed ID: 2145808
    [Abstract] [Full Text] [Related]

  • 24. [Clinical and cytological characteristics of endometrial cancer under radiation therapy].
    Titova VA, Titova NP.
    Med Radiol (Mosk); 1981 May; 26(5):21-7. PubMed ID: 6165876
    [No Abstract] [Full Text] [Related]

  • 25. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
    Lindahl B, Willén R.
    Anticancer Res; 1991 May; 11(1):403-6. PubMed ID: 1826823
    [Abstract] [Full Text] [Related]

  • 26. Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
    Kauppila A, Vihko R.
    Acta Obstet Gynecol Scand; 1981 May; 60(6):589-90. PubMed ID: 6461159
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H, Spitalier JM, Ayme Y, Degiovanni E, Bardin JP.
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970 May; 22(1):93-7. PubMed ID: 5453572
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ, Deppe G, Bruckner HW.
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The status of receptors in the management of endometrial cancer.
    Richardson GS, MacLaughlin DT.
    Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Conservative organ-preserving measures in precancerous stages of endometrial cancer].
    Dallenbach-Hellweg G.
    Gynakologe; 1988 Dec; 21(4):302-7. PubMed ID: 2974824
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G, De Hertogh R, Bonte J, Ide P, Vlaemynck G.
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract] [Full Text] [Related]

  • 39. [Growth of endometrial cancer and hormone].
    Kanoh H, Hosono T, Matsui Y, Okudaira Y.
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.